Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IBCP | CPF |
|---|---|---|
| Price | $35.55 | $35.81 |
| Change today | ▼ 0.67% | ▼ 1.30% |
| Market cap | $789.18M | $922.02M |
| Return, 3 months | +0.9% | -5.4% |
| Return, year to date | +11.9% | +17.8% |
| Return, 1 year | +17.8% | +25.0% |
| P/E (TTM) | 10.3 | 11.5 |
| P/B | 1.5 | 1.5 |
| P/E percentile vs own 5y | 72nd | 57th |
| Dividend yield | 3.04% | 3.16% |
| Revenue growth (YoY, latest qtr) | +12.8% | +6.7% |
| Net profit growth (YoY) | +11.4% | +14.0% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 31.2% | 27.9% |
| Return on equity | 14.4% | 14.2% |
| Analyst target vs. price | +13.4% | +14.5% |
| Analyst buy share | 50% | 33% |
| RSI (14) | 42 | 36 |
| 30-day volatility | 15.6% | 14.6% |
| Max drawdown, 1 year | -13.5% | -11.0% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.